Small Cap📈 ASX: PAR
Paradigm Biopharmaceuticals Limited (ASX: PAR)
Published 1 August 2025PG Weekly Pick
Paradigm Biopharmaceuticals Limited
ASX:
PAR
Paradigm Biopharmaceuticals Ltd. is a biopharmaceutical company engaged in researching and developing therapeutic products for human use. It is a drug repurposing company which seeks to find new uses for old drugs. The company was founded by P
🔒
Subscribers only
Sign in with your subscriber account or subscribe to access this research report.
Required subscription
PG Weekly Pick
A$100.00
Already a subscriber?
Sign in to read this report.
Required subscription
PG Weekly Pick
Receive one high-conviction ASX stock idea every week, backed by detailed research, risk analysis, and a clear investment thesis designed to help you focus on quality opportunities.
- ✓ One Premium ASX Stock Pick Weekly
- ✓ Delivered Every Friday
- ✓ Buy / Hold / Sell Guidance & Risk Rating
- ✓ Full Historical Pick Access
A$100.00/ 1 months
Risk:High
Subscribe Now →
